• about hartington pharma

Congratulations to our winner!

Hartington Pharma Ltd. is proud to announce the winner from our Partner's Survey of 2014.

The fantastic AMAZON VOUCHER (valued 100€) goes to...

ASTRID REGOUT from OmegaPharma!

 

Thank you to all our partners who participated in HPH survey of 2014. Your opinion is very important to us!

We'll keep working to bring you the best!

Hartington Pharmaceutical

Sinus course 2013

Hartington Group is very proud to have participated and sponsored, the XI "Endoscopy Sinus Surgery Course", which took place on 11th-13th of April 2013 in Barcelona. The event was attended by some of the best sinus experts in the world.

The main objectives of the course were to review the endoscopy anatomy of the nose and sinuses, as well as improving endoscopy surgical skills. The programme was divided into theoretical and practical sessions.

Recognized names, such as Dr.Mullol, Dr.Bernal, Dr. Alobid, Dr. Fokkens, Bachert, Dr. Massegur, Dr. Montserrat, Dr. Pasquini, Dr. Kamel and Dr. Eloy, among other distinguished professionals, joined more than 60 specialists in the Ear Nose and Throat field. 20 speakers contributed to making this noteworthy, international sinus course possible.

Read more...

Hartington Pharmaceutical

Nasodren® available in South America

Hartington Pharma has reached an agreement with Closter pharma to distribute Nasodren® in South America. This new venture is an important step towards introducing our product in a new continent.

Closter distributes and promotes pharmaceutical products from Big pharma companies in South America, focusing on innovative products for Colombia, Brazil, Chile, Ecuador, Mexico, Peru and Venezuela.


We are delighted to welcome all of our Closter colleagues to the Hartington Group.

Read more...

Hartington Pharmaceutical

Extension territories

ANNAHDAH Medical company, established in 1971, is a pioneer in the medical field in Saudi Arabia (KSA).

This leading company will extend Nasodren to Kuwait, Bahrain, Oman, Qatar, Iraq, Syria, Jordan, Lebanon, Yemen, Palestine, Egypt, Libya, Tunisia, Algeria, Morocco, Sudan, Mauritania, Somalia, Djibouti and Iran, entering these markets with the support of their local knowledge and thereby establishing a key role in the success of our international marketing strategy.

From 2013 Nasodren will extend to 20 new African and Middle Eastern countries.

Read more...

Hartington Pharmaceutical